The Cost-Effectiveness of Human Immunodeficiency Virus Testing and Treatment Engagement Initiatives in British Columbia, Canada: 2011–2013

Recognition of the secondary preventive benefits of antiretroviral therapy (ART) has mobilized global efforts to “seek, test, treat, and retain” people living with human immunodeficiency virus [HIV]/AIDS (PLHIV) in HIV care. We aimed to determine the cost-effectiveness of a set of HIV testing and treatment engagement interventions initiated in British Columbia, Canada, in 2011–2013. Using a previously validated dynamic HIV transmission model,...